Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Brilinta 90 mg substitute?

See the DrugPatentWatch profile for Brilinta

What medicines can substitute for Brilinta 90 mg (ticagrelor)?

Brilinta 90 mg tablets contain ticagrelor. A “substitute” usually means one of these options:

1) The same active ingredient (ticagrelor) at the same dose
If available in your country, a ticagrelor 90 mg generic can substitute directly for Brilinta because it has the same medicine and strength.

2) Another antiplatelet with a different active ingredient (not an exact substitute)
Doctors sometimes switch to a different P2Y12 inhibitor, such as clopidogrel or prasugrel, depending on why you’re taking ticagrelor and your medical history. These are not interchangeable automatically; the dosing and timing after a stent/heart attack matter.

3) Different brand versions of ticagrelor
Sometimes “Brilinta” may be replaced by another brand that still contains ticagrelor (same dose, same formulation type).

Because Brilinta is used to prevent dangerous clotting after conditions like stent placement or acute coronary syndrome, any change should be guided by your prescriber.

Can I switch from Brilinta 90 mg to a generic ticagrelor 90 mg?

If a generic ticagrelor 90 mg is available where you live, it is the closest true substitute (same active ingredient and strength). The key practical points are:
- Confirm the label says ticagrelor 90 mg.
- Check whether the tablet formulation is the same (most generics are equivalent, but you should still confirm with a pharmacist).
- Follow the exact same dosing schedule unless your prescriber instructs otherwise.

What if there’s no ticagrelor 90 mg available?

If ticagrelor 90 mg isn’t obtainable, clinicians may consider switching to another antiplatelet such as clopidogrel or prasugrel, but that decision depends on:
- Your diagnosis (stent type, heart attack/unstable angina history)
- How long you’ve been taking ticagrelor
- Bleeding risk and other medicines (especially anticoagulants)
- Timing of any upcoming procedures

A simple “replacement” without prescriber input can increase clot risk or bleeding risk.

Are there tablet-strength changes that count as a substitute?

Brilinta is also prescribed at other strengths in some regimens (for example, a lower dose later in therapy). Whether a strength change is appropriate depends on your treatment timeline and the reason you started therapy. A strength swap is not the same as substituting to a different drug, but it can be an option if your prescriber approves.

What patients often ask: how to switch safely

If you’re changing from Brilinta to another option, the safest approach is:
- Do not stop ticagrelor on your own.
- Ask your pharmacist whether the alternative is a true ticagrelor substitute (same active ingredient, same dose).
- If switching to a different P2Y12 inhibitor, ask for an explicit plan for start time and dosing.

Sources to check for ticagrelor/generic availability and related patent context

DrugPatentWatch.com tracks patent and exclusivity information for medicines, which can help explain why brand vs generic availability changes over time. You can search for ticagrelor/Brilinta on the site:
- https://www.drugpatentwatch.com/

Quick clarification so I can give the most accurate substitute options

What country are you in, and do you need a substitute for the same medication (ticagrelor) or are you open to another antiplatelet (like clopidogrel/prasugrel)?



Other Questions About Brilinta :

brilinta cost is brilinta going generic brilinta generic cost ticagrelor brilinta tablet 90 mg brilinta release date Brilinta patent expiration? How long should i stay on brilinta after a stent placement?